Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Times Interest Earned (2016 - 2017)

CytomX Therapeutics (CTMX) has disclosed Times Interest Earned for 4 consecutive years, with -$41.82 as the latest value for Q1 2017.

  • For the quarter ending Q1 2017, Times Interest Earned rose 8.78% year-over-year to -$41.82, compared with a TTM value of -$224.56 through Dec 2017, down 536.52%, and an annual FY2016 reading of -$35.28, down 84.03% over the prior year.
  • Times Interest Earned was -$41.82 for Q1 2017 at CytomX Therapeutics, down from -$36.58 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$13.58 in Q2 2015 and bottomed at -$45.84 in Q1 2016.
  • Average Times Interest Earned over 4 years is -$30.97, with a median of -$30.8 recorded in 2016.
  • The sharpest move saw Times Interest Earned grew 28.3% in 2015, then plummeted 125.74% in 2016.
  • Year by year, Times Interest Earned stood at -$42.74 in 2014, then grew by 28.3% to -$30.65 in 2015, then dropped by 19.35% to -$36.58 in 2016, then decreased by 14.31% to -$41.82 in 2017.
  • Business Quant data shows Times Interest Earned for CTMX at -$41.82 in Q1 2017, -$36.58 in Q4 2016, and -$30.95 in Q3 2016.